Medifast Launches Trilivy, Comprehensive Metabolic Health System; Co. Also Unveils Newly Formulated Meal Replacements, Including Trilivy Reset Fueling Line Enhanced With MetaVantage Technology

MNST's International Sales Surge 35%: Is Global Expansion Paying Off?

Monster Beverage's international sales jumped 34.6% to $1.16B in Q2 2026, now representing 46% of total sales. Strong growth in EMEA (27.2%), Asia-Pacific (35.7%), and Latin America (56.1%) is driven by product innovation, cooler placements, and Coca-Cola bottler partnerships. However, lower overseas margins and inflation in aluminum, freight, and fuel pose challenges. The stock trades at a premium 36.59X forward P/E, well above the industry average of 19.32X.

11 Consumer Staples Stocks Moving In Monday's After-Market Session

Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came out today.

Medifast shares are trading higher after the company reported better-than-expected Q2 financial results.

Medifast Sees Q3 GAAP EPS $(0.65)-$(0.15) vs $(0.62) Est; Sees Sales $60.000M-$80.000M vs $67.700M Est

Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees sales of $60.000 million-$80.000 million vs $67.700 million analyst estimate.